Insulin resistance is a condition where your cells stop responding normally to insulin, the hormone that moves sugar from your bloodstream into your cells for energy. Your pancreas compensates by producing more and more insulin, and for a while, this extra output keeps blood sugar in a normal range. But the underlying problem is already doing damage: elevated insulin levels drive fat storage, inflammation, and a cascade of metabolic changes that can eventually lead to type 2 diabetes, heart disease, and other serious conditions.
How Insulin Normally Works
When you eat, your blood sugar rises and your pancreas releases insulin. Insulin binds to receptors on the surface of your cells, triggering a chain reaction inside the cell. That signal opens channels that allow glucose to move from the blood into muscle, fat, and liver cells, where it’s either burned for energy or stored for later.
The system works through two main internal pathways. One controls glucose uptake and energy storage. The other influences cell growth and gene expression. In a healthy body, these pathways respond quickly and efficiently to even small amounts of insulin. The whole process is tightly regulated by feedback loops: once enough glucose has been absorbed, the signal dials itself down.
What Goes Wrong in Insulin Resistance
In insulin resistance, the signaling chain inside your cells becomes disrupted. One key mechanism involves the docking proteins that relay the insulin signal after it arrives at the cell surface. These proteins have dozens of sites where chemical tags can be added. Certain tags activate the signal and move glucose into the cell. Others, particularly those triggered by inflammation, shut the signal down. Chronic inflammation essentially jams the relay system, so even when insulin binds to the receptor, the message doesn’t get through properly.
Inflammatory molecules produced by excess fat tissue are a major driver of this interference. They activate stress pathways inside cells that suppress insulin signaling. This creates a vicious cycle: insulin resistance promotes fat accumulation, and fat tissue produces more inflammation, which worsens resistance. Meanwhile, a specific enzyme in the cell’s recycling machinery strips insulin receptors of their active state, further reducing sensitivity. The net result is that your pancreas has to produce far more insulin to achieve the same effect, and circulating insulin levels climb.
What Causes It
Excess body fat, particularly fat stored around the organs in your abdomen (visceral fat), is the strongest driver. Waist circumference is one of the simplest predictors of risk. Research across multiple populations has identified thresholds in the range of 84 to 90 cm (33 to 35 inches) for men and 75 to 80 cm (30 to 31 inches) for women, depending on ethnicity, as the point where insulin resistance risk rises sharply.
Diet composition matters independently of total calories. Fructose, in particular, behaves differently from glucose in your body. While glucose circulates widely and is used by cells throughout the body, fructose is almost entirely captured by the liver on its first pass through. The liver converts fructose into fatty acids, which accumulate in liver tissue and trigger a specific form of hepatic insulin resistance. High fructose intake promotes visceral fat accumulation, raises blood triglycerides, and activates pathways that block insulin signaling in the liver. This is one reason sugary drinks and processed foods with added sugars are so consistently linked to metabolic problems.
Physical inactivity, poor sleep, chronic stress, certain medications (like long-term steroid use), and genetics all contribute. Aging is a factor too, as muscle mass naturally declines and fat distribution shifts toward the midsection.
Signs and Symptoms
Insulin resistance often produces no obvious symptoms for years, which is why it’s sometimes called a “silent” condition. But there are clues. Fatigue after meals, difficulty losing weight (especially around the midsection), frequent hunger or sugar cravings, and brain fog are common early complaints.
One visible sign is acanthosis nigricans: patches of darkened, velvety skin that appear in body folds, most commonly the back of the neck, armpits, and groin. This happens because high insulin levels stimulate growth factor receptors in skin cells, causing them to multiply faster than normal. In children, the back of the neck is the most typical location. Skin tags in the same areas often accompany these patches.
Other indicators include rising blood pressure, elevated triglycerides, and low HDL (“good”) cholesterol, all of which tend to develop gradually.
How It’s Measured
There is no single standard test for insulin resistance, but the most commonly used clinical tool is the HOMA-IR score, calculated from your fasting blood sugar and fasting insulin levels. A large population study using validated methods found that a normal reference range for fasting insulin falls between roughly 2.5 and 13 μIU/mL, with a corresponding HOMA-IR range of 0.39 to 2.86. Values above this range suggest insulin resistance is present.
Research in adolescents using gold-standard testing (the hyperglycemic clamp) found that HOMA-IR values above approximately 2.9 to 3.2 reliably identified insulin resistance, depending on developmental stage. These cutoffs vary somewhat by age, sex, weight, and ethnicity, which is why your lab’s reference range may differ from published values. The important pattern to watch for is a fasting insulin level that’s creeping upward over time, even if your blood sugar still looks normal.
The Link to Metabolic Syndrome
Insulin resistance is the engine behind metabolic syndrome, a cluster of five risk factors that dramatically increase your chance of developing heart disease, stroke, and type 2 diabetes. You meet the criteria for metabolic syndrome if you have three or more of the following: a waist circumference over 102 cm (40 inches) for men or 88 cm (35 inches) for women, triglycerides at or above 150 mg/dL, HDL cholesterol below 40 mg/dL for men or 50 mg/dL for women, blood pressure at or above 130/85 mmHg, and fasting blood sugar at or above 110 mg/dL.
Each of these five markers is independently tied to insulin resistance. They tend to appear together because they share a common metabolic root. You don’t need to have all five to be at risk. Even one or two of these markers, combined with a rising HOMA-IR, is a signal that your metabolism is heading in the wrong direction.
Insulin Resistance and PCOS
Polycystic ovary syndrome is one of the most common conditions linked to insulin resistance in women. The relationship between body weight and insulin resistance in PCOS is striking: among women with PCOS and a BMI of 30 or higher, 88% showed significant insulin resistance. At a BMI between 25 and 30, that number dropped to 42%. Lean women with PCOS (BMI under 25) showed only mild deficiencies in glucose uptake compared to women without the condition.
Excess insulin stimulates the ovaries to produce more androgens (male hormones), which disrupts ovulation and drives symptoms like irregular periods, acne, and hair thinning. Improving insulin sensitivity is often a central part of managing PCOS, regardless of whether weight loss is needed.
What Reverses It
The most effective interventions target the same pathways that caused the problem. Exercise improves insulin sensitivity through a mechanism that’s partly independent of insulin itself: contracting muscles pull glucose directly out of the bloodstream without needing insulin to open the door. Both aerobic exercise and resistance training produce this effect.
Consistency matters more than intensity, and the timeline for measurable improvement is specific. A study in young women found that four weeks of moderate aerobic exercise (at 40 to 70% of maximum heart rate) was not enough to significantly reduce HOMA-IR scores, but eight weeks of the same program produced a 14.6% improvement. This suggests that the metabolic adaptations driving better insulin sensitivity need at least two months to establish themselves.
Dietary changes that reduce fructose and refined sugar intake, increase fiber, and shift the balance toward whole foods can lower the liver’s fat burden and reduce visceral fat. Losing even a modest amount of weight, particularly from the midsection, has outsized effects on insulin sensitivity because visceral fat is the most metabolically active type. Sleep improvements and stress management also help by lowering cortisol and inflammatory signaling that interfere with insulin pathways.
The encouraging reality is that insulin resistance, especially in its early stages, is highly reversible. The same feedback loops that made it worse can work in your favor: improved sensitivity reduces insulin levels, which makes it easier to lose fat, which further improves sensitivity. Getting that cycle moving in the right direction is the core strategy.